Latest Options News

QuickFee Limited reports mixed Q4 FY25 results with solid growth in US Pay Now and Australian Finance, offset by a significant US Finance decline due to credit impairment. The company completes a major refinancing and capital raise while maintaining FY25 earnings guidance.

OncoSil Medical has launched a Security Purchase Plan offering discounted shares and free options to eligible shareholders, aiming to accelerate commercialization of its pancreatic cancer treatment device.

Chimeric Therapeutics has secured FDA Fast Track designation for its CHM CDH17 CAR-T therapy targeting gastroenteropancreatic neuroendocrine tumours, accelerating its path toward regulatory approval and patient access.

Ovanti Limited is set to raise approximately $1 million through a two-tranche share placement to support its US buy now, pay later expansion and ongoing legal matters.

New Frontier Minerals has secured $1.59 million in funding to launch its inaugural drilling campaign targeting heavy rare earth elements, niobium, and uranium at the Harts Range Project, aligning with favorable US policies on supply chain diversification and nuclear energy.

Star Minerals has completed a $1.6 million placement, welcoming Bain Global Resources as a strategic investor and gearing up for drilling at its Tumblegum South Gold Project.

Pursuit Minerals has dispatched high-purity lithium carbonate samples from its Argentine pilot plant to potential partners, advancing feasibility studies for a 5,000tpa operation while exploring strategic acquisitions in precious and base metals.

Metals X Limited has announced a pre-conditional voluntary cash partial offer to acquire up to 28% of Greentech Technology International Limited at HK$0.35 per share, aiming to increase its stake in the joint venture behind the Renison Tin Mine. The offer follows Greentech's failure to meet pre-conditions for a full takeover and comes amid ongoing trading suspension and delayed financial results.

Radiopharm Theranostics has initiated dosing in its Phase 1 HEAT trial of 177Lu-RAD202, a novel radiotherapeutic aimed at advanced HER2-positive solid tumors, marking a key step in its clinical development.

PointsBet has secured a significantly improved acquisition proposal from MIXI, lifting the cash offer by 13.2% to $1.20 per share and postponing the shareholder vote to June 25. The move intensifies the takeover battle amid ongoing regulatory approvals and a rival bid from Betr Entertainment.

Asra Minerals Limited has launched a substantial options offer linked to a recent $3 million placement, aiming to enhance liquidity and satisfy obligations under the placement. The company plans to list these options on the ASX by the end of June 2025.

Magnum Mining and Exploration Limited has announced a pro-rata entitlement offer to raise up to $2.24 million, aiming to fund key exploration projects across Brazil, the US, and Nevada. The offer carries significant dilution risks for non-participating shareholders and underscores ongoing operational uncertainties.